These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39003823)

  • 1. Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2.
    Miyazaki Y; Niino M; Takahashi E; Sato C; Naganuma R; Amino I; Akimoto S; Minami N; Kikuchi S
    Mult Scler Relat Disord; 2024 Sep; 89():105768. PubMed ID: 39003823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.
    Wanitschek A; Seebacher B; Muehlbacher A; Brenneis C; Ehling R
    Mult Scler Relat Disord; 2024 May; 85():105532. PubMed ID: 38452648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
    Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
    Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW; Plummer P; Backus D; Hebert JR; Neal WN; Ng A; Lowman J; Bethoux F; Schmidt H; McBurney R; McCully KK; Cutter G
    Mult Scler Relat Disord; 2024 Aug; 88():105715. PubMed ID: 38889558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
    de David AC; Sasaki JE; Ramari C; Tauil CB; Moraes AG; Martins F; von Glehn F; Motl RW
    Mult Scler Relat Disord; 2019 May; 30():208-214. PubMed ID: 30818129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.
    Kim W; Park EY; Hyun JW; Huh SY; Park NY; Jang H; Kim SH; Kim HJ
    J Clin Neurol; 2020 Apr; 16(2):270-276. PubMed ID: 32319244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Sclerosis Walking Scale-12, translation, adaptation and validation for the Persian language population.
    Nakhostin Ansari N; Naghdi S; Mohammadi R; Hasson S
    Gait Posture; 2015 Feb; 41(2):420-4. PubMed ID: 25444584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.
    Motl R; Neal W; Backus D; Hebert J; McCully K; Bethoux F; Plummer P; Ng A; Lowman J; Schmidt H; McBurney R; Cutter G
    BMC Neurol; 2024 Oct; 24(1):383. PubMed ID: 39390466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian validation of the 12-item multiple sclerosis walking scale.
    Solaro C; Trabucco E; Signori A; Cella M; Messmer Uccelli M; Brichetto G; Cavalla P; Gironi M; Patti F; Prosperini L
    Mult Scler Int; 2015; 2015():540828. PubMed ID: 25883806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerometry as a measure of walking behavior in multiple sclerosis.
    Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
    Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
    Marangoni BE; Pavan K; Tilbery CP
    Arq Neuropsiquiatr; 2012 Dec; 70(12):922-8. PubMed ID: 23295419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P
    Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
    Bosma L; Kragt JJ; Polman CH; Uitdehaag BM
    Mult Scler; 2013 Mar; 19(3):326-33. PubMed ID: 22907939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.
    Bennett SE; Bromley LE; Fisher NM; Tomita MR; Niewczyk P
    Int J MS Care; 2017; 19(5):247-252. PubMed ID: 29070965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a feasibility and initial efficacy clinical trial of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability.
    Silveira SL; Motl RW; Elmer DJ; Botkin T; Ontiveros T; Williams S; Hubbard EA
    Mult Scler Relat Disord; 2024 Jul; 87():105695. PubMed ID: 38820697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.